naltrexone has been researched along with Complications, Pregnancy in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (17.39) | 29.6817 |
| 2010's | 15 (65.22) | 24.3611 |
| 2020's | 4 (17.39) | 2.80 |
| Authors | Studies |
|---|---|
| Greenland, M; Kelty, E; Preen, D; Terplan, M | 1 |
| Ahrens, K; Allen, L; Austin, A; Barnes, AJ; Burns, M; Chang, CH; Clark, S; Cole, E; Crane, D; Cunningham, P; Donohue, JM; Gordon, AJ; Idala, D; Jarlenski, MP; Junker, S; Kennedy, S; Kim, JY; Lanier, P; Mauk, R; McDuffie, MJ; Mohamoud, S; Pauly, N; Sheets, L; Talbert, J; Tang, L; Zivin, K | 1 |
| Hulse, G; Kelty, E | 2 |
| Griffin, BL; Stone, RH; Todd, TJ; Tran, TH; Vest, KM | 1 |
| Jones, CW; Terplan, M | 1 |
| Landau, R | 1 |
| Carter, G; Jones, H; Miller, M; Saia, K; Shrestha, H; Valle, E; Wachman, EM; Werler, M | 1 |
| Glance, JB; Gopalan, P; Kmiec, J; Spada, M | 1 |
| Katz, E; Towers, CV; Visconti, K; Weitz, B | 1 |
| Flynn, PM; Friedmann, PD; Frisman, LK; Gordon, M; Hall, E; Hoskinson, R; Kinlock, T; Knight, K; Knudsen, HK; O'Connell, DJ; Sacks, S; Schwartz, R; Shafer, MS; Stein, LA; Welsh, WN | 1 |
| Chisolm, MS; Jansson, LM; Jones, HE; Terplan, M | 2 |
| Hulse, G; Kunøe, N; Lobmaier, P; Ngo, H | 1 |
| Chervenak, FA; Coverdale, JH; McCullough, LB | 1 |
| Stitzer, ML | 1 |
| White, J | 1 |
| Waal, H | 1 |
| Clark, N; Verster, A | 1 |
| Hulse, G; O'Neil, G | 1 |
| Arnold-Reed, DE; Hansson, RC; Hulse, GK; O'Neil, G | 1 |
| Arnold-Reed, DE; Hulse, GK; O'Neil, G | 1 |
| Brewer, C; Hulse, GK; O'Neill, G; Pereira, C | 1 |
8 review(s) available for naltrexone and Complications, Pregnancy
| Article | Year |
|---|---|
Pharmacotherapies for the Treatment of Alcohol Use Disorders During Pregnancy: Time to Reconsider?
Topics: Acamprosate; Alcohol Abstinence; Alcohol Deterrents; Alcoholism; Animals; Comorbidity; Disulfiram; Female; Fetal Alcohol Spectrum Disorders; Humans; Naltrexone; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Substance Withdrawal Syndrome | 2021 |
Use of Medications for Treatment of Opioid Use Disorder Among US Medicaid Enrollees in 11 States, 2014-2018.
Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Child; Cross-Sectional Studies; Female; Humans; Male; Medicaid; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; United States; Young Adult | 2021 |
A Retrospective Cohort Study of Obstetric Outcomes in Opioid-Dependent Women Treated with Implant Naltrexone, Oral Methadone or Sublingual Buprenorphine, and Non-Dependent Controls.
Topics: Administration, Oral; Administration, Sublingual; Buprenorphine; Drug Implants; Female; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retrospective Studies | 2017 |
Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Naltrexone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Treatment Outcome | 2017 |
Post-cesarean delivery pain. Management of the opioid-dependent patient before, during and after cesarean delivery.
Topics: Analgesia, Patient-Controlled; Buprenorphine; Cesarean Section; Female; Humans; Methadone; Naltrexone; Opioid-Related Disorders; Pain, Postoperative; Pregnancy; Pregnancy Complications | 2019 |
Consideration of opioid agonist treatment in a pregnant adolescent: A case report and literature review.
Topics: Adolescent; Ambulatory Care; Analgesics, Opioid; Buprenorphine; Child, Foster; Female; Humans; Lost to Follow-Up; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications; Pregnancy in Adolescence | 2020 |
Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research.
Topics: Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Risk Assessment; Risk Factors; Treatment Outcome | 2013 |
Injectable and implantable sustained release naltrexone in the treatment of opioid addiction.
Topics: Delayed-Action Preparations; Drug Implants; Female; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Prisoners; Time Factors | 2014 |
15 other study(ies) available for naltrexone and Complications, Pregnancy
| Article | Year |
|---|---|
A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
Topics: Adult; Australia; Buprenorphine; Drug Administration Routes; Female; Humans; Incidence; Infant, Newborn; Male; Methadone; Naltrexone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Retrospective Studies | 2017 |
Pregnancy and Naltrexone Pharmacotherapy.
Topics: Adult; Delivery, Obstetric; Female; Humans; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Pain, Postoperative; Pregnancy; Pregnancy Complications | 2018 |
Naltrexone Treatment for Pregnant Women With Opioid Use Disorder Compared With Matched Buprenorphine Control Subjects.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Humans; Infant, Newborn; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Pilot Projects; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retrospective Studies; Treatment Outcome | 2019 |
Use of naltrexone in treating opioid use disorder in pregnancy.
Topics: Abortion, Spontaneous; Adult; Analgesics, Opioid; Buprenorphine; Case-Control Studies; Female; Humans; Infant, Newborn; Methadone; Naltrexone; Narcotic Antagonists; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Prospective Studies; Stillbirth; Young Adult | 2020 |
Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions.
Topics: Adult; Buprenorphine; Crime; Criminal Law; Data Collection; Female; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Pregnancy; Pregnancy Complications; Prisons; Substance-Related Disorders; Young Adult | 2012 |
An ethical framework for conducting research on pregnant, opioid-dependent women.
Topics: Ethics, Medical; Female; Humans; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Research Design | 2013 |
Dual dilemma-should naltrexone be used in the treatment of opioid-dependent pregnant women?
Topics: Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Risk Assessment; Treatment Outcome | 2013 |
Blocking endogenous opioids during development--do we understand the consequences?
Topics: Animals; Brain; Buprenorphine; Female; Fetal Development; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Treatment Outcome | 2013 |
Is sustained release natrexone an option for heroin-dependent pregnant women?
Topics: Animals; Female; Fetus; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Rats; Research Design | 2013 |
Double trouble-pregnancy and antagonist treatment in opioid dependence; two contentious issues needing further consideration and research.
Topics: Buprenorphine; Female; Humans; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic; Research Design; Substance Withdrawal Syndrome | 2013 |
Naltrexone in the treatment of opioid-dependent pregnant women: common ground.
Topics: Animals; Brain; Buprenorphine; Ethics, Medical; Female; Fetal Development; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Research Design | 2013 |
Using naltrexone implants in the management of the pregnant heroin user.
Topics: Adult; Drug Implants; Female; Heroin Dependence; Humans; Infant, Newborn; Male; Naltrexone; Narcotic Antagonists; Pregnancy; Pregnancy Complications; Pregnancy Outcome | 2002 |
Naltrexone implant and blood naltrexone levels over pregnancy.
Topics: Adult; Drug Implants; Female; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Pregnancy; Pregnancy Complications | 2003 |
Methadone maintenance vs. implantable naltrexone treatment in the pregnant heroin user.
Topics: Australia; Drug Implants; Female; Heroin Dependence; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Pregnancy; Pregnancy Complications; Pregnancy Outcome | 2004 |
Obstetric and neonatal outcomes associated with maternal naltrexone exposure.
Topics: Adult; Australia; Female; Heroin Dependence; Humans; Infant, Newborn; Naltrexone; Narcotic Antagonists; Portugal; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimesters; United Kingdom | 2001 |